Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · IEX Real-Time Price · USD
+0.33 (2.09%)
Jul 16, 2024, 4:00 PM EDT - Market closed

Orthofix Medical Revenue

Orthofix Medical had revenue of $760.05M in the twelve months ending March 31, 2024, with 43.54% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $188.61M with 7.65% year-over-year growth. In the year 2023, Orthofix Medical had annual revenue of $746.64M with 62.06% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
605.72M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023746.64M285.93M62.06%
Dec 31, 2022460.71M-3.77M-0.81%
Dec 31, 2021464.48M57.92M14.25%
Dec 31, 2020406.56M-53.39M-11.61%
Dec 31, 2019459.96M6.91M1.53%
Dec 31, 2018453.04M19.22M4.43%
Dec 31, 2017433.82M24.04M5.87%
Dec 31, 2016409.79M13.30M3.35%
Dec 31, 2015396.49M-5.79M-1.44%
Dec 31, 2014402.28M4.67M1.17%
Dec 31, 2013397.61M-42.58M-9.67%
Dec 31, 2012440.19M4.67M1.07%
Dec 31, 2011435.52M-27.05M-5.85%
Dec 31, 2010462.57M-83.06M-15.22%
Dec 31, 2009545.64M25.96M5.00%
Dec 31, 2008519.68M29.35M5.99%
Dec 31, 2007490.32M124.96M34.20%
Dec 31, 2006365.36M52.06M16.61%
Dec 31, 2005313.30M26.67M9.30%
Dec 31, 2004286.64M82.93M40.71%
Dec 31, 2003203.71M26.11M14.70%
Dec 31, 2002177.60M--
Dec 31, 2001177.60M45.81M34.76%
Dec 31, 2000131.78M10.50M8.66%
Dec 31, 1999121.28M17.22M16.55%
Dec 31, 1998104.07M14.10M15.68%
Dec 31, 199789.96M12.74M16.50%
Dec 31, 199677.22M24.95M47.73%
Dec 31, 199552.27M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Aveanna Healthcare Holdings 1.92B
Varex Imaging 855.80M
Pharming Group 280.83M
Adaptive Biotechnologies 174.50M
Surmodics 142.96M
Allogene Therapeutics 65.00K
Revenue Rankings